<DOC>
	<DOCNO>NCT01318655</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability NKTR-118 healthy subject .</brief_summary>
	<brief_title>Single Multiple Ascending Dose Study NKTR-118 Cross-over Study Investigate Effect Food NKTR-118 Japanese Healthy Subjects</brief_title>
	<detailed_description>A Phase I , Randomized , Double-Blind , Placebo-Controlled Study Assess Safety , Tolerability Pharmacokinetics NKTR-118 follow single multiple ascend oral dose administration healthy young elderly Japanese subject , Open Randomized , Crossover Study Investigate Effect Food Pharmacokinetics single oral dos NKTR-118 healthy male Japanese subject</detailed_description>
	<mesh_term>Naloxegol</mesh_term>
	<criteria>20 Years 45 Years , 65 Years 80 Years Body mass index ( BMI ) : 18 27 kg/m Male subject willing use barrier contraception ie , condom , day dose 3 month dose investigational product . Nonsmokers exsmokers ( smoke past 3 month ) . Clinically relevant disease and/or abnormality ( past present ) Clinically relevant abnormality physical examination , vital sign , clinical chemistry , hematology urinalysis judge investigator Use prescribe nonprescribed medication include herbal remedy , vitamin mineral two week prior first administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Japan</keyword>
	<keyword>SAD</keyword>
	<keyword>MAD</keyword>
</DOC>